Engineering Immune Tolerance with Biomaterials

Overview

Journal Adv Healthc Mater

Specialties Biomedical Engineering
Biotechnology

Date 2019 Jan 4

PMID 30605264

Citations 32

Authors

Joshua M Gammon

Christopher M Jewell

Affiliations

Soon will be listed here.

Abstract

Autoimmune diseases, rejection of transplanted organs and grafts, chronic inflammatory diseases, and immune-mediated rejection of biologic drugs impact a large number of people across the globe. New understanding of immune function is revealing exciting opportunities to help tackle these challenges by harnessing-or correcting-the specificity of immune function. However, realizing this potential requires precision control over the interaction between regulatory immune cues, antigens attacked during inflammation, and the tissues where these processes occur. Engineered materials-such as polymeric and lipid particles, scaffolds, and inorganic materials-offer powerful features that can help to selectively regulate immune function during disease without compromising healthy immune functions. This review highlights some of the exciting developments to leverage biomaterials as carriers, depots, scaffolds-and even as agents with intrinsic immunomodulatory features-to promote immunological tolerance.

Citing Articles

Immunometabolism of Liver Xenotransplantation and Prospective Solutions.

Deng S, Zhang Y, Shen S, Li C, Qin C Adv Sci (Weinh). 2025; 12(9):e2407610.

PMID: 39912334 PMC: 11884532. DOI: 10.1002/advs.202407610.

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.

Song Y, Li J, Wu Y Signal Transduct Target Ther. 2024; 9(1):263.

PMID: 39362875 PMC: 11452214. DOI: 10.1038/s41392-024-01952-8.

Tailoring biomaterials for vaccine delivery.

Zhuo Y, Zeng H, Su C, Lv Q, Cheng T, Lei L J Nanobiotechnology. 2024; 22(1):480.

PMID: 39135073 PMC: 11321069. DOI: 10.1186/s12951-024-02758-0.

Dendritic cell force-migration coupling on aligned fiber networks.

Hernandez-Padilla C, Joosten B, Franco A, Cambi A, van den Dries K, Nain A Biophys J. 2024; 123(18):3120-3132.

PMID: 38993114 PMC: 11427780. DOI: 10.1016/j.bpj.2024.07.011.

Development of protein-polymer conjugate nanoparticles for modulation of dendritic cell phenotype and antigen-specific CD4 T cell responses.

Scotland B, Cottingham A, Lasola J, Hoag S, Pearson R ACS Appl Polym Mater. 2024; 5(11):8794-8807.

PMID: 38911349 PMC: 11192461. DOI: 10.1021/acsapm.3c00548.

References

Wibroe P, Anselmo A, Nilsson P, Sarode A, Gupta V, Urbanics R . Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat Nanotechnol. 2017; 12(6):589-594. DOI: 10.1038/nnano.2017.47. View

Graham J, Zhang X, Goodman A, Pothoven K, Houlihan J, Wang S . PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. Tissue Eng Part A. 2013; 19(11-12):1465-75. PMC: 3638535. DOI: 10.1089/ten.TEA.2012.0643. View

Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, Serra P . Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity. 2010; 32(4):568-80. DOI: 10.1016/j.immuni.2010.03.015. View

Yeste A, Takenaka M, Mascanfroni I, Nadeau M, Kenison J, Patel B . Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2. Sci Signal. 2016; 9(433):ra61. DOI: 10.1126/scisignal.aad0612. View

Lewis J, Roche C, Zhang Y, Brusko T, Wasserfall C, Atkinson M . Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres. J Mater Chem B. 2014; 2(17):2562-2574. PMC: 4000038. DOI: 10.1039/C3TB21460E. View

Wadwa M, Klopfleisch R, Buer J, Westendorf A . Targeting Antigens to Dec-205 on Dendritic Cells Induces Immune Protection in Experimental Colitis in Mice. Eur J Microbiol Immunol (Bp). 2016; 6(1):1-8. PMC: 4838981. DOI: 10.1556/1886.2015.00048. View

Cho J, Stewart J, Drashansky T, Brusko M, Zuniga A, Lorentsen K . An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis. Biomaterials. 2017; 143:79-92. PMC: 5870833. DOI: 10.1016/j.biomaterials.2017.07.029. View

Verbeke C, Gordo S, Schubert D, Lewin S, Desai R, Dobbins J . Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation. Adv Healthc Mater. 2017; 6(6). PMC: 5518671. DOI: 10.1002/adhm.201600773. View

Meyer R, Sunshine J, Perica K, Kosmides A, Aje K, Schneck J . Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation. Small. 2015; 11(13):1519-25. PMC: 4529071. DOI: 10.1002/smll.201402369. View

10.

Getts D, Turley D, Smith C, Harp C, McCarthy D, Feeney E . Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol. 2011; 187(5):2405-17. PMC: 3159828. DOI: 10.4049/jimmunol.1004175. View

11.

Ludvigsson J, Wahlberg J, Casas R . Intralymphatic Injection of Autoantigen in Type 1 Diabetes. N Engl J Med. 2017; 376(7):697-699. DOI: 10.1056/NEJMc1616343. View

12.

Hartwell B, Smalter Hall A, Swafford D, Sullivan B, Garza A, Sestak J . Molecular Dynamics of Multivalent Soluble Antigen Arrays Support a Two-Signal Co-delivery Mechanism in the Treatment of Experimental Autoimmune Encephalomyelitis. Mol Pharm. 2015; 13(2):330-43. DOI: 10.1021/acs.molpharmaceut.5b00825. View

13.

McGaha T, Chen Y, Ravishankar B, van Rooijen N, Karlsson M . Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood. 2011; 117(20):5403-12. DOI: 10.1182/blood-2010-11-320028. View

14.

Gammon J, Adapa A, Jewell C . Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors. J Biomed Mater Res A. 2017; 105(11):2977-2985. DOI: 10.1002/jbm.a.36151. View

15.

Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S . Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice. J Immunol. 2015; 195(12):5533-7. PMC: 4670795. DOI: 10.4049/jimmunol.1501603. View

16.

Bookstaver M, Hess K, Jewell C . Self-Assembly of Immune Signals Improves Codelivery to Antigen Presenting Cells and Accelerates Signal Internalization, Processing Kinetics, and Immune Activation. Small. 2018; 14(38):e1802202. PMC: 6252008. DOI: 10.1002/smll.201802202. View

17.

De Groot A, Scott D . Immunogenicity of protein therapeutics. Trends Immunol. 2007; 28(11):482-90. DOI: 10.1016/j.it.2007.07.011. View

18.

Luo X, Miller S, Shea L . Immune Tolerance for Autoimmune Disease and Cell Transplantation. Annu Rev Biomed Eng. 2016; 18:181-205. PMC: 4947009. DOI: 10.1146/annurev-bioeng-110315-020137. View

19.

Casey L, Pearson R, Hughes K, Liu J, Rose J, North M . Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance. Bioconjug Chem. 2017; 29(3):813-823. PMC: 6850215. DOI: 10.1021/acs.bioconjchem.7b00624. View

20.

Balmert S, Donahue C, Vu J, Erdos G, Falo Jr L, Little S . In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis. J Control Release. 2017; 261:223-233. PMC: 9169568. DOI: 10.1016/j.jconrel.2017.07.006. View